MichBio supports a strong, full-funded FDA with the resources necessary to keep with rapidly-evolving biomedical and life science technologies, and to make thorough, timely and efficient regulatory decisions. FDA regulates approximately 25 cents of every U.S. consumer dollar spent, and it is critical that the agency have the latest tools, resources and talent necessary to effectively ensure food, drug and device quality, safety and efficacy.
MichBio joins its national industry partners in requesting that Congress appropriate a minimum of $2.8 billion (not including user fees) to the FDA as part of the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act. Adequate funding would ensure implementation and oversight of several key programs and initiatives:
Human drugs and biologics program;
Advancing Regulatory Science Initiative;
Medical Countermeasures Initiatives (MCMi);
Drug Quality and Security Act of 2013;
Sufficient funding for a sound, science-based FDA is vital to the public health and the U.S. bio-industry as new biomedical innovations will mean better patient access to novel treatments and therapies.